Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Ruffolo

Showing results (191-200 of 230) with videos related to

Pageof 23
Sort By:
Journal of Cardiovascular Pharmacology|September 1, 1988
Evaluation of the acute hemodynamic effects and pharmacokinetics of coronary thrombolysis produced by intravenous tissue-type plasminogen activator in the anesthetized dogG A Kopia, L J Kopaciewicz, K L Fong, et al.
Journal of Medicinal Chemistry|September 1, 1985
N-substituted imidazolines and ethylenediamines and their action on alpha- and beta-adrenergic receptorsA Hamada, E L Yaden, J S Horng, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
The selectivity in vitro of the stereoisomers of the beta-3 adrenoceptor agonist BRL 37344M A Oriowo, H Chapman, D M Kirkham, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1993
Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cellsT L Yue, P J Mckenna, J L Gu, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
Carvedilol, a new beta-adrenoreceptor blocker, vasodilator and free-radical scavenger, exerts an anti-shock and endothelial protective effect in rat splanchnic ischemia and reperfusionT A Christopher, B L Lopez, T L Yue, et al.
British Journal of Pharmacology|March 7, 1998
Effects of a hydroxylated metabolite of the beta-andrenoreceptor antagonist, carvedilol, on post-ischaemic splachnic tissue injuryT A Christopher, B L Lopez, X L Ma, et al.
Annals of the New York Academy of Sciences|November 17, 1994
Carvedilol, a new antihypertensive drug with unique antioxidant activity: potential role in cerebroprotectionT L Yue, P G Lysko, F C Barone, et al.
Biochemical Pharmacology|June 1, 1981
Properties of 8,9-dichloro-2,3,4,5-tetrahydro-1H-2-benzazepine, an inhibitor of norepinephrine N-methyltransferaseR W Fuller, S Hemrick-Luecke, R E Toomey, et al.
Canadian Journal of Physiology and Pharmacology|May 1, 1995
Vascular alpha-adrenoceptors: from the gene to the humanD B Bylund, J W Regan, J E Faber, et al.
Journal of Cardiovascular Pharmacology|August 15, 2000
A comparison of carvedilol and metoprolol antioxidant activities in vitroP G Lysko, C L Webb, J L Gu, et al.
Pageof 23

Showing results (191-200 of 230) with videos related to

Sort By:
Pageof 23
Journal of Cardiovascular Pharmacology|September 1, 1988
Evaluation of the acute hemodynamic effects and pharmacokinetics of coronary thrombolysis produced by intravenous tissue-type plasminogen activator in the anesthetized dogG A Kopia, L J Kopaciewicz, K L Fong, et al.
Journal of Medicinal Chemistry|September 1, 1985
N-substituted imidazolines and ethylenediamines and their action on alpha- and beta-adrenergic receptorsA Hamada, E L Yaden, J S Horng, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1996
The selectivity in vitro of the stereoisomers of the beta-3 adrenoceptor agonist BRL 37344M A Oriowo, H Chapman, D M Kirkham, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1993
Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cellsT L Yue, P J Mckenna, J L Gu, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
Carvedilol, a new beta-adrenoreceptor blocker, vasodilator and free-radical scavenger, exerts an anti-shock and endothelial protective effect in rat splanchnic ischemia and reperfusionT A Christopher, B L Lopez, T L Yue, et al.
British Journal of Pharmacology|March 7, 1998
Effects of a hydroxylated metabolite of the beta-andrenoreceptor antagonist, carvedilol, on post-ischaemic splachnic tissue injuryT A Christopher, B L Lopez, X L Ma, et al.
Annals of the New York Academy of Sciences|November 17, 1994
Carvedilol, a new antihypertensive drug with unique antioxidant activity: potential role in cerebroprotectionT L Yue, P G Lysko, F C Barone, et al.
Biochemical Pharmacology|June 1, 1981
Properties of 8,9-dichloro-2,3,4,5-tetrahydro-1H-2-benzazepine, an inhibitor of norepinephrine N-methyltransferaseR W Fuller, S Hemrick-Luecke, R E Toomey, et al.
Canadian Journal of Physiology and Pharmacology|May 1, 1995
Vascular alpha-adrenoceptors: from the gene to the humanD B Bylund, J W Regan, J E Faber, et al.
Journal of Cardiovascular Pharmacology|August 15, 2000
A comparison of carvedilol and metoprolol antioxidant activities in vitroP G Lysko, C L Webb, J L Gu, et al.
Pageof 23